Organon & Co.
Organon & Co. is a global health care company focused on improving the health of women through a diverse portfolio of products in women's health, biosimilars, and established brands. The company's women's health portfolio includes contraception and fertility products, such as Nexplanon, NuvaRing, Follistim AQ, and Elonva. Organon's biosimilars portfolio includes Hadlima, Brenzys, Renflexis, Aybintio, and Ontruzant. The company's established brands cover various therapeutic areas, including cardiovascular, respiratory, dermatology, bone health, and non-opioid pain management. Organon has six manufacturing sites and a global supply chain, employing approximately 10,000 people worldwide. The company's website is organon.com, and its ticker symbol is ORGN.